Significance of Results of the Antibody Test at 3 Months and 4½ Months
58 As stated earlier, Dr Grigor was the first specialist to have the clinical care of Jacob. He suspected that congenital CMV was the cause of Jacob's disabilities. On 4 November 1992 he arranged for Jacob to have a urine test and blood test. As part of the blood test, he ordered a TORCH study, which is a study looking for five specific infections including CMV. The test for CMV within the TORCH spectrum is known as a complement fixation test (CFT). That test measures a combination of IgM and IgG. The urine test was positive for CMV. Negative results were reported for all infections within the TORCH spectrum. Dr Grigor found this surprising because he suspected that Jacob had congenital CMV. Dr Grigor thus requested a more specific test to detect if there were any detectable M and G immuglobins (IgM and IgG respectively).
59 IgM and IgG are both antibodies produced at the time the body suffers an infection. IgM is produced at the time of the infection, its function being to 'mop up' the virus. If found, it indicates recent infection. IgM disappears from the person's system within a few weeks and does not cross the placenta. IgG is produced 2-3 weeks after an infection and persists in the body. Its function is to assist the body to resist further infection but it is relatively ineffective in the case of CMV.
60 The further testing requested by Dr Grigor was not done at that time.
61 Dr Grigor ordered a further blood test on Jacob six weeks later, on 18 December 1992. It too returned a negative result, which Dr Grigor again found surprising. However, the negative result did not cause him to change his provisional diagnosis of congenital CMV.
62 Dr Grigor said that when trying to reconcile the two negative results with his opinion:
"I reasoned that it was most unlikely that the infection was peri or postnatal because I would have expected a baby to produce antibodies in that period of time in a normal way and one would see a change between the level of the complement CFT at three months and one at three months plus six weeks.
…
Whereas if it had occurred in utero, … I could reason, without being aware that it was proven to be so in other circumstances, other cases, that the baby had failed to manufacture antibodies in utero, on the basis that, that his body recognised the [CMV] as itself and so did not see itself as a foreign antigen, a foreign stimulant to producing antibodies."
63 It was suggested by senior counsel for the cross-respondent at trial that there was in fact an alternative explanation for the negative results, namely that Jacob was developing CMV between the two tests. Dr Grigor rejected that explanation because of the positive urine test result at three months.
64 Dr Grigor believed he again asked for an IgM/IgG specific test in December 1992 but that the laboratory advised that there was no point in its being carried out. There was some confusion about this part of the evidence. The better view seems to be that the more specific testing was not carried out.
65 Professor Isaacs also expressed the view that it was surprising that if Jacob did have congenital CMV he had no detectable antibodies at 3 months and at 4½ months. He explained:
"If you then showed me the antibody results, I would say, 'This is very strange. I don't understand why there is no antibody in Jacob's blood, both at three months and possibly that traced at four and a half months. It doesn't make sense.' If you try to ask me to explain why that would be, my best explanation for that is that he's tolerant and that would only happen following primary maternal infection. In other words, he is incapable of producing antibodies."
66 Professor Isaacs' reference to "possibly … four and a half months" in this passage related to the confusion as to whether the more sensitive testing ordered by Dr Grigor was in fact carried out. When that matter was clarified, Professor Isaacs was of the view that Jacob's antibody count at three months was only explicable by primary infection. He first explained:
"Q You said that if it was, if there had been a reactivation, … you would have expected lots and lots of antibodies?
A That's correct.
Q In whom?
A Both the mother and the baby, because the antibody goes across the placenta.
Q That would be likely, whether it was primary or secondary infection wouldn't it?
A No. If I have to explain it - we now assume that Jacob did have symptomatic congenital CMV infection. Now as a doctor if I am asked, 'Do you think this was primary or non-primary?', I would say, 'On the basis of the results, of the probabilities, it's likely to be primary but not absolute', as his Honour says. If you then showed me the antibody results, I would say, 'This is very strange. I don't understand why there is no antibody in Jacob's blood, both at three months and possibly that traced at four and a half months. It doesn't make sense.' If you try to ask me to explain why that would be, my best explanation for that is that he's tolerant and that would only happen following primary maternal infection. In other words, he is incapable of producing antibodies.
…
Q … the same antibody created IgG will show in the foetus, whether or not it is a primary or secondary infection, won't it?
A There are two points I would like to make to that. The first is it won't - it doesn't usually have the same effect on the foetus, because the antibody that is around already, is thought to be relatively protective to the foetus.
Having said that, if you get a reinfection that's, for example, if you have had measles before and you get measles again, you produce a vast amount of antibodies. It is a question of degree. You would [expect] lots of antibodies with a reinfection and not so many antibodies necessarily with a primary one."
67 A little later he said:
"A. … there are three possibilities. One is that Jacob did not have congenital CMV infection. That's why he has no antibody but it's all coincidence that he caught CMV incidentally after birth and all his malformations is a co-incidence. They are due to something else. If we reject that possibility, there are two major considerations left.
One is that he caught CMV infection inutero, as a result of primary maternal CMV and the other is as a result of non-primary. If we assume it's one of those, we then have to explain why he does not produce antibodies at three months in both settings.
The books would tell us we would expect to find antibodies at three months, a lot of it spilling over from his mother and that as that waned he would produce his own antibodies. So at three months and again at four and a half months, we would expect high levels of IgG.
The best explanation I can come up with, to explain this unlikely phenomenon, is that Jacob has tolerance. That is much more likely to occur. In fact, I think it could only occur with primary maternal CMV, not non-primary.
HIS HONOUR: Q. Why?
…
A. Because he, as a baby, would have needed to - it has to be a new antigen and if it was non-primary, he would effectively have already seen the virus and therefore could not become tolerant to it. Tolerance is a phenomenon whereby it's the very first time that a virus gets into your system."
68 The absence of antibodies at 3 and 4½ months was relevant to the respondent's case, including Dr Rawlinson's opinion, that Jacob did not have congenital CMV. Dr Rawlinson gave evidence that if Jacob had congenital CMV (whether primary or reactivated) there was an 85-90% probability of a positive IgG at three months. He explained the positive urine test at 3 months as indicating that Jacob had acquired CMV post-natally and probably at about 3 months. In that case, the only explanation he could give for Jacob not having antibodies at 4½ months was that he had an immature immune system. Neither Professor Isaacs or Dr Grigor accepted this.
69 Dr Rawlinson considered that Dr Grigor and Professor Isaacs' explanation as to why Jacob did not have antibodies at 3 or 4½ months, assuming he had congenital CMV to be a plausible hypothesis but one that he did not accept. He remained of the opinion that the reason for the absence of antibodies was because Jacob did not have congenital CMV.
70 It is of importance in the appeal, for reasons which will become apparent, that the trial judge said that he did "not find that evidence that the absence of antibodies ruled out reactivated infection to be persuasive". It is to be noted that evidence to that effect was not included in the catalogue of findings drawn together by his Honour (see para 20 above). It is necessary to refer to the particular evidence upon which his Honour relied in reaching this conclusion.
71 During the course of his cross examination, Professor Isaacs was being questioned in relation to the antibody evidence. He was asked a series of questions by his Honour. Immediately after his Honour's questioning referred to at para 66 above, senior counsel for the respondent asked him this question:
"Q As a matter of logic, the reason why Jacob was injured, was because he had a viral attack, on your thesis. Is that right?